Ets Variant 7 (ETV7) Peptide
-
- Target See all ETV7 products
- ETV7 (Ets Variant 7 (ETV7))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ETV7 antibody (Catalog #: ARP35903_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ETV7 (Ets Variant 7 (ETV7))
- Synonyms
- BmEts Peptide, TEL-2 Peptide, TEL2 Peptide, TELB Peptide, ETS variant 7 Peptide, transcription factor Ets Peptide, ETV7 Peptide, Ets Peptide
- Background
-
As a transcriptional repressor, ETV7 binds to the DNA sequence 5'-CCGGAAGT-3'. But Isoform A and isoform C do not seem to have a repressor activity.
Alias Symbols: TEL-2, TEL2, TELB
Protein Interaction Partner: L3MBTL,L3MBTL
Protein Size: 341 - Molecular Weight
- 39 kDa
- Gene ID
- 51513
- NCBI Accession
- NM_016135, NP_057219
- UniProt
- Q9Y603
-